All In MedTech

Device Trial Radar · NCT07901374

Genicular Nerve Radiofrequency Ablation Versus Hyaluronic Acid Injection for Knee Osteoarthritis Pain

A Prospective Comparative Study of Conventional Conservative Treatment Versus Genicular Radiofrequency Ablation in Non-Surgical Knee Osteoarthritis: A Randomized Controlled Trial of Thermal Radiofrequency of the Genicular Nerves Versus Intra-Articular Hyaluronic Acid

Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

70

Planned (sponsor's estimate)

Start

Nov 2026

Primary completion

May 2028

Study completion May 2028

Sponsor

Lead sponsor
Hospital Universitari Joan XXIII de Tarragona.Academic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Institut Investigacio Sanitaria Pere Virgili
First posted
Oct 28, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to learn if thermal radiofrequency ablation of the genicular nerves (the nerves that carry pain signals from the knee) works better than a single injection of hyaluronic acid into the knee to relieve pain in adults with knee osteoarthritis who have not improved with conservative treatment. The study also includes patients with severe knee osteoarthritis who are not candidates for knee replacement surgery. The main questions it aims to answer are: * Does genicular nerve radiofrequency reduce knee pain during movement more than hyaluronic acid over 12 months? * Does it improve knee function and quality of life, and does its effect last longer? Researchers will compare radiofrequency ablation with hyaluronic acid injection to see which treatment gives greater and longer-lasting pain relief. Participants will: * Be randomly assigned to one of the two treatments. * If assigned to radiofrequency, first receive a diagnostic nerve block with local anesthetic. Only those whose pain decreases by at least 50% will then receive radiofrequency ablation, in a single ultrasound-guided session. * If assigned to hyaluronic acid, receive a single injection of hyaluronic acid into the knee. * Attend follow-up visits at 1, 3, 6 and 12 months, where they will rate their pain and answer questionnaires about knee function, overall status and quality of life.

Conditions

  • Knee Osteoarthritis
  • Chronic Knee Pain

Interventions

  • Thermal Radiofrequency Ablation of the Genicular NervesProcedure

    Ultrasound-guided thermal radiofrequency ablation (80 C, 90 seconds per nerve) of the superomedial, superolateral and inferomedial genicular nerves, performed only after a positive diagnostic block (\>=50% pain reduction within 4 hours after 1 ml of 1% lidocaine per nerve).

  • Intra-articular Hyaluronic AcidDevice

    Single 6 ml intra-articular injection of high molecular weight hyaluronic acid into the index knee.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Knee Pain During Movement (Visual Analogue Scale)Time frame: Baseline, 1, 3, 6 and 12 months after the intervention

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hospital Universitari Joan XXIII de Tarragona

    Tarragona, Tarragona, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.